Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

PAVmed Q1 Adj. EPS $(0.07) Beats $(0.13) Estimate, Sales $8.00K Miss $10.00K Estimate

Author: Benzinga Newsdesk | May 15, 2025 07:02am
PAVmed (NASDAQ:PAVM) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.13) by 46.15 percent. This is a 92.93 percent increase over losses of $(0.99) per share from the same period last year. The company reported quarterly sales of $8.00 thousand which missed the analyst consensus estimate of $10.00 thousand by 20.00 percent. This is a 99.21 percent decrease over sales of $1.01 million the same period last year.

Posted In: PAVM


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist